Blue shark score among the most abundant, widely distributed and worldwide consumed elasmobranchs. In this work contents of PCBs, PCDD/Fs and PBDEs were studied by means of GC-HRMS in muscle and liver of sixty blue sharks from the North East Atlantic sampled in 2019. Concentrations relatively similar were found for PCBs and PCDD/Fs in comparison with those in Atlantic specimens from the same area sampled in 2015. In contrast, PBDE loads doubled, likely mirroring the increased environmental presence of these pollutants. This, together with the different congener profiles reported for the same species in other geographical areas, highlighted the blue shark's potential as bioindicator of the degree and fingerprints of regional pollution by POPs. Interesting dissimilarities between muscle and liver concentrations were detected, most likely ascribed to distinct toxicokinetics involved for the different pollutants. Whereas most POPs preferentially accumulated in liver, some did the opposite in muscle. BDE-209 was the most prominent example, being almost negligible its presence in liver (0.3%) while accounting for ca. 14% of the total PBDE content in muscle. Different findings in this regard described for other shark species call for focused research to ascertain the role of the species in this apparent favored metabolization of BDE-209 in the liver. From a consumption perspective, the concentrations found in muscle -the most relevant part in the human diet-for PCBs and dioxin-like POPs were below the EU maximum allowed levels in foodstuff. Conversely, in liver about 58% and 78% of samples overpassed the European levels for tolerable intake of i-PCBs and dioxin POPs, respectively. Concentrations of PBDEs exceeded EQS (0.0085 ng/g w.w.) established by the European Water Framework Directive in 100% and 92% of liver and muscle samples, respectively, which adds to the open debate of such as a reduce value for this current EQS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envpol.2022.119750 | DOI Listing |
J Gastroenterol
January 2025
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Background: Advanced liver fibrosis in cases of metabolic dysfunction-associated steatotic liver disease (MASLD) leads to cirrhosis and hepatocellular carcinoma. The current gold standard for liver fibrosis is invasive liver biopsy. Therefore, a less invasive biomarker that accurately reflects the stage of liver fibrosis is highly desirable.
View Article and Find Full Text PDFSurg Endosc
January 2025
Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Background: Both laparoscopic hepatectomy (LH) and robotic hepatectomy (RH) have been performed for tumors in nearly all liver segments. However, few studies have compared the outcomes of patients who underwent open hepatectomy (OH), LH and RH for the treatment of Barcelona Clinic Liver Cancer (BCLC) stage 0-A HCC in S7/8.
Methods: The clinical data of patients who underwent S7/8 resection for the treatment of BCLC stage 0-A HCC in the First Affiliated Hospital of Guangxi Medical University from July 2017 to July 2023 were retrospectively collected.
Signal Transduct Target Ther
January 2025
Department of Hepatobiliary Surgery, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
CD8T cells within the tumor microenvironment (TME) are often functionally impaired, which limits their ability to mount effective anti-tumor responses. However, the molecular mechanisms behind this dysfunction remain incompletely understood. Here, we identified valosin-containing protein (VCP) as a key regulator of CD8T cells suppression in hepatocellular carcinoma (HCC).
View Article and Find Full Text PDFAcad Radiol
January 2025
Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China (Q.L., J.O., Y.Z., J.Z.). Electronic address:
Rationale And Objectives: The purpose of this study was to demonstrate the impact of postoperative adjuvant transarterial chemoembolization (TACE) on the prognosis of patients with macrotrabecular-massive hepatocellular carcinoma (MTM-HCC).
Materials And Methods: This retrospective study used the clinical records of patients with resected MTM-HCC with/without adjuvant TACE at three centers between January 2015 and December 2022. The primary end point was recurrence free survival (RFS).
J Formos Med Assoc
January 2025
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan. Electronic address:
Background: Limited data exists regarding the long-term serum ferritin dynamics following sustained virologic response (SVR) and factors associated with trends in changes among patients undergoing treatment for hepatitis C virus (HCV).
Methods: Serum ferritin levels were assessed biannually in 1538 participants undergoing direct-acting antivirals (DAAs) or peginterferon plus ribavirin (PR) with a median of follow-up of 5.0 years after off-treatment week 12.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!